FDA’s Hamburg Details Some Sequestration Impacts On FDA
Commissioner says allowing the sequester could slow implementation of some user fee provisions and reduce overseas inspections.
Commissioner says allowing the sequester could slow implementation of some user fee provisions and reduce overseas inspections.